Side-by-side comparison of AI visibility scores, market position, and capabilities
FY 2025 (ended Jan 31, 2025): Revenue $2.977B (+8% YoY); 1.7M customers in 180 countries; 1B+ users; 1,131 customers with $300K+ ACV (up from 1,060 in 2024)
DocuSign CLM is the contract lifecycle management platform from DocuSign, the San Francisco-based agreement cloud company founded in 2003. While DocuSign's eSignature product revolutionized document execution, CLM addresses the broader contract management lifecycle — authoring, negotiation, approval workflows, obligation tracking, and renewal management — giving legal, sales, and procurement teams a unified system for every stage of a contract from first draft to renewal. The platform's core technology uses AI to extract, classify, and surface contract metadata from both executed agreements and legacy documents.\n\nDocuSign CLM serves enterprise customers in financial services, life sciences, technology, and professional services who manage high volumes of complex contracts with multiple counterparties and jurisdictions. Key differentiators include deep integration with DocuSign eSignature, Salesforce, and major ERP systems, enabling contracts to flow automatically through CRM and procurement workflows. The Intelligent Agreement Management layer — powered by DocuSign AI — adds risk flagging, obligation extraction, and clause recommendations that reduce legal review time and surface buried contract risks.\n\nDocuSign reported FY2025 revenue of $2.977 billion, an 8% year-over-year increase, with 1.7 million customers across 180 countries and more than one billion users having touched the platform. The company counts 1,131 customers with $300,000+ annual contract values, reflecting strong enterprise adoption of its expanded platform beyond eSignature. As companies face increasing pressure to extract value from contracted commitments and reduce compliance risk, DocuSign CLM's position within the world's most trusted agreement infrastructure gives it a privileged entry point into enterprise contract intelligence.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.